Free Account Opening + AMC Free Demat
Loading...

Concord Biotech IPO vs Vishnu Prakash R Punglia IPO

Comparision between Concord Biotech IPO and Vishnu Prakash R Punglia IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Vishnu Prakash R Punglia IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Vishnu Prakash R Punglia IPO is up to ₹308.88 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Vishnu Prakash R Punglia IPO is ₹99.00 per share.

  Concord Biotech IPO Vishnu Prakash R Punglia IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹705.00 per share ₹94.00 per share
Issue Price (Upper) ₹741.00 per share ₹99.00 per share
Issue Price (Final) ₹741.00 per share ₹99.00 per share
Discount (Retail)
Discount (Employee) ₹70.00 per share ₹9.00 per share
Market Lot Size 20 shares 150 shares
Fresh Issue Size 3,12,00,000 shares
Fresh Issue Size (Amount)
OFS Issue Size 2,09,25,652 shares
OFS Issue Size (Amount) up to ₹1,551.00 Cr
Issue Size Total 2,09,25,652 shares 3,12,00,000 shares
Issue Size Total (Amount) up to ₹1,551.00 Cr up to ₹308.88 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while Vishnu Prakash R Punglia IPO opens on Aug 24, 2023. The closing date of Concord Biotech IPO and Vishnu Prakash R Punglia IPO is Aug 08, 2023, and Aug 28, 2023, respectively.

  Concord Biotech IPO Vishnu Prakash R Punglia IPO
Anchor Bid Date Aug 03, 2023 Aug 23, 2023
Issue Open Aug 04, 2023 Aug 24, 2023
Issue Close Aug 08, 2023 Aug 28, 2023
Basis Of Allotment (Tentative) Aug 11, 2023 Aug 31, 2023
Initiation of Refunds (Tentative) Aug 14, 2023 Sep 01, 2023
Credit of Share (Tentative) Aug 17, 2023 Sep 04, 2023
Listing date (Tentative) Aug 18, 2023 Sep 05, 2023
Anchor Lockin End date 1 Sep 10, 2023 Sep 30, 2023
Anchor Lockin End date 2 Nov 09, 2023 Nov 29, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to Vishnu Prakash R Punglia IPO P/E ratio of 13.61.

  Concord Biotech IPO Vishnu Prakash R Punglia IPO
Financial
Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets1,182.551,312.801,513.98
Revenue630.75736.35888.48
Profit After Tax234.89174.93240.08
Net Worth999.371,103.221,290.00
Reserves and Surplus
Total Borrowing86.3560.5931.24
Amount in ₹ Crore
Vishnu Prakash R Punglia IPO Financial Information (Restated Standalone)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets331.05497.81825.48
Revenue487.67787.391,171.46
Profit After Tax18.9844.8590.64
Net Worth113.61158.69314.51
Reserves and Surplus85.24130.11219.96
Total Borrowing110.78176.58250.37
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 44.08% 90.45%
Promoter Shareholding (Post-Issue) 44.08% 67.81%
P/E Ratio 32.29 13.61
Market Cap ₹7752.06 Cr. ₹1234.00 Cr.
ROE 20.06%%
ROCE 24.27%% 33.72%%
Debt/Equity 0.8
EPS ₹20.79 ₹10.41
RoNW 20%% 38.31%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Vishnu Prakash R Punglia IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 61,80,000 shares in Vishnu Prakash R Punglia IPO.

  Concord Biotech IPO Vishnu Prakash R Punglia IPO
Anchor Investor Reserveration 62,74,695 shares 92,70,000 shares
Market Maker Reserveration
QIB 41,83,130 shares 61,80,000 shares
NII 31,37,348 shares 46,35,000 shares
RII 73,20,479 shares 1,08,15,000 shares
Employee 10,000 shares 3,00,000 shares
Others
Total 1,46,50,957 shares 2,19,30,000 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas Vishnu Prakash R Punglia IPO subscribed 87.82x.

  Concord Biotech IPO Vishnu Prakash R Punglia IPO
QIB (times) 67.67x 171.69x
NII (times) 16.99x 111.03x
Big NII (times) 19.30x 112.02x
Small NII (times) 12.37x 109.07x
RII (times) 3.78x 32.01x
Employee (times) 24.48x 12.97x
Other (times)
Total (times) 24.87x 87.82x

Comments

Add a public comment...